Spironolactone lactation

See references Feb 1, 2024 · Breastfeeding Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding. Spironolactone is not present in breastmilk; however, limited data from a lactating woman at 17 days postpartum reports the presence of the active metabolite, canrenone, in human breast milk in low amounts that are expected to be clinically inconsequential

2024-03-28
    Micron bag design
  1. 6
  2. In: Drugs and Lactation Database (LactMed) [Internet]
  3. 2 Lactation
  4. Bethesda (MD): National Library of Medicine (US); 2006–
  5. Pregnancy and Lactation
  6. 2 %) would be received by a breastfeeding infant
  7. 4
  8. 2 Lactation
  9. Spironolactone